- Home
- MKSI vs GH Comparison
MKSI vs GH Comparison
Compare MKSI & GH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MKSI
- GH
- Stock Information
- Founded
- MKSI 1961
- GH 2011
- Country
- MKSI United States
- GH United States
- Employees
- MKSI N/A
- GH N/A
- Industry
- MKSI Industrial Machinery/Components
- GH Medical Specialities
- Sector
- MKSI Industrials
- GH Health Care
- Exchange
- MKSI Nasdaq
- GH Nasdaq
- Market Cap
- MKSI 5.0B
- GH 4.9B
- IPO Year
- MKSI 1999
- GH 2018
- Fundamental
- Price
- MKSI $104.62
- GH $50.18
- Analyst Decision
- MKSI Buy
- GH Strong Buy
- Analyst Count
- MKSI 11
- GH 20
- Target Price
- MKSI $131.73
- GH $54.35
- AVG Volume (30 Days)
- MKSI 931.0K
- GH 2.2M
- Earning Date
- MKSI 08-06-2025
- GH 08-06-2025
- Dividend Yield
- MKSI 0.84%
- GH N/A
- EPS Growth
- MKSI N/A
- GH N/A
- EPS
- MKSI 3.36
- GH N/A
- Revenue
- MKSI $3,654,000,000.00
- GH $773,996,000.00
- Revenue This Year
- MKSI $7.00
- GH $23.14
- Revenue Next Year
- MKSI $6.70
- GH $21.42
- P/E Ratio
- MKSI $31.14
- GH N/A
- Revenue Growth
- MKSI N/A
- GH 28.20
- 52 Week Low
- MKSI $54.84
- GH $20.14
- 52 Week High
- MKSI $147.40
- GH $53.42
- Technical
- Relative Strength Index (RSI)
- MKSI 71.89
- GH 59.50
- Support Level
- MKSI $97.16
- GH $48.07
- Resistance Level
- MKSI $100.80
- GH $53.42
- Average True Range (ATR)
- MKSI 3.03
- GH 2.20
- MACD
- MKSI 0.70
- GH -0.06
- Stochastic Oscillator
- MKSI 99.37
- GH 50.68
About MKSI MKS Instruments Inc.
MKS Instruments Inc is engaged in providing instruments, subsystems, and process control systems used to measure, monitor, deliver, and control parameters of manufacturing processes. The company's product portfolio includes instruments, components, and systems required in manufacturing products such as flat panel displays, medical devices, and electronic materials, among others used in industrial technologies, semiconductors, life and health sciences, and research and defense markets. The company organizes itself into three reportable business segments: Vacuum Solutions, Photonics Solutions, and Materials Solutions. The Vacuum Solutions segment contributes the majority of the company's revenue.
About GH Guardant Health Inc.
Guardant Health, Inc, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant OMNI, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease, or MRD, test. In 2024, the company received US FDA approval for Shield, a liquid biopsy for colorectal cancer, or CRC, screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.